Literature DB >> 16414404

Stroke after varicose vein foam injection sclerotherapy.

Martin V Forlee1, Maria Grouden, Dermot J Moore, Gregor Shanik.   

Abstract

This report describes an ischemic stroke after foam injection sclerotherapy of varicose veins in a patient with a patent foramen ovale. Foam injection sclerotherapy has created resurgence in the minimally invasive treatment of varicose veins. The United States Food and Drug Administration halted a clinical phase 2 trial of a commercial preparation of polidocanol microfoam in 2003 because of concerns relating to possible gas embolism. These trials were recommenced in July 2005. Neurologic complications such as transient visual disturbances and transient confusional states have previously been reported. This case, with its strong circumstantial evidence, illustrates the previously unconfirmed potential for embolic complications using this technique.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16414404     DOI: 10.1016/j.jvs.2005.09.032

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  23 in total

Review 1.  Venous malformation: update on aetiopathogenesis, diagnosis and management.

Authors:  A Dompmartin; M Vikkula; L M Boon
Journal:  Phlebology       Date:  2010-10       Impact factor: 1.740

Review 2.  Varicose veins and their management.

Authors:  Bruce Campbell
Journal:  BMJ       Date:  2006-08-05

3.  Balloon-occluded Retrograde Transvenous Obliteration (BRTO): Technique and Intraprocedural Imaging.

Authors:  Saher S Sabri; Wael E A Saad
Journal:  Semin Intervent Radiol       Date:  2011-09       Impact factor: 1.513

4.  Compression sclerotherapy for primary valvular insufficiency -from liquid to foam-.

Authors:  Takashi Yamaki
Journal:  Ann Vasc Dis       Date:  2010-07-21

Review 5.  [Guidelines for sclerotherapy of varicose veins : S2k guideline of the German Society of Phlebology (DGP) in cooperation with the following professional associations: DDG, DGA, DDG, BVP. German Version].

Authors:  E Rabe; F X Breu; I Flessenkämper; H Gerlach; S Guggenbichler; B Kahle; R Murena; S Reich-Schupke; T Schwarz; M Stücker; E Valesky; S Werth; F Pannier
Journal:  Hautarzt       Date:  2021-01       Impact factor: 0.751

6.  Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO).

Authors:  Sun Young Choi; Jong Yun Won; Kyung Ah Kim; Do Yun Lee; Kwang-Hun Lee
Journal:  Eur Radiol       Date:  2010-08-26       Impact factor: 5.315

Review 7.  Visual loss following sclerotherapy for varicose veins.

Authors:  James Chiung Yoong Leong; Nicholas Robert Johnston
Journal:  BMJ Case Rep       Date:  2011-01-25

8.  Intra-arterial air thrombogenesis after cerebral air embolism complicating lower extremity sclerotherapy.

Authors:  T M Leslie-Mazwi; Laura L Avery; John R Sims
Journal:  Neurocrit Care       Date:  2009-03-17       Impact factor: 3.210

9.  Intra-arterial air thrombogenesis after cerebral air embolism complicating lower extremity sclerotherapy.

Authors:  T M Leslie-Mazwi; Laura L Avery; John R Sims
Journal:  Neurocrit Care       Date:  2009-03-11       Impact factor: 3.210

Review 10.  Polidocanol for endovenous microfoam sclerosant therapy.

Authors:  David M Eckmann
Journal:  Expert Opin Investig Drugs       Date:  2009-12       Impact factor: 6.206

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.